Compare COR & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COR | BDX |
|---|---|---|
| Founded | 2001 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.5B | 51.5B |
| IPO Year | 2001 | 1994 |
| Metric | COR | BDX |
|---|---|---|
| Price | $351.66 | $163.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $395.23 | $189.60 |
| AVG Volume (30 Days) | 934.6K | ★ 2.5M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | 0.68% | ★ 2.56% |
| EPS Growth | ★ 5.71 | N/A |
| EPS | ★ 2.87 | 1.34 |
| Revenue | ★ $321,332,819,000.00 | $21,840,000,000.00 |
| Revenue This Year | $8.97 | N/A |
| Revenue Next Year | $6.76 | $2.53 |
| P/E Ratio | $122.90 | ★ $122.76 |
| Revenue Growth | ★ 9.31 | 8.24 |
| 52 Week Low | $252.49 | $161.75 |
| 52 Week High | $377.54 | $231.82 |
| Indicator | COR | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 42.65 | 25.83 |
| Support Level | $331.73 | N/A |
| Resistance Level | $353.18 | $177.73 |
| Average True Range (ATR) | 7.16 | 4.15 |
| MACD | -2.18 | -1.02 |
| Stochastic Oscillator | 6.37 | 9.58 |
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.